Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse

Author： Gordon M.N. Holcomb L.A. Jantzen P.T. DiCarlo G. Wilcock D. Boyett K.W. Connor K. Melachrino J. O'Callaghan J.P. Morgan D.

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.173, Iss.2, 2002-02, pp. : 183-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease

Current Alzheimer Research, Vol. 12, Iss. 1, 2015-01 ,pp. : 22-31

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Long-Term Treatment with Metrifonate, a Cholinesterase Inhibitor, on Cholinergic Activity, Amyloid Pathology, and Cognitive Function in APP and PS1 Doubly Transgenic Mice

By Liu L. Ikonen S. Heikkinen T. Tapiola T. van Groen T. Tanila H.

Experimental Neurology, Vol. 173, Iss. 2, 2002-02 ,pp. : 196-204

Elsevier

Access to resources Recommend Favorite

Valproic Acid Attenuates Neuronal Loss in the Brain of APP/PS1 Double Transgenic Alzheimer's Disease Mice Model

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 261-269

Bentham Science Publishers

Access to resources Recommend Favorite

Synaptic Fatigue is More Pronounced in the APP/PS1 Transgenic Mouse Model of Alzheimer's Disease

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 137-140

Bentham Science Publishers

Access to resources Recommend Favorite

Time sequence of maturation of dystrophic neurites associated with A deposits in APP/PS1 transgenic mice

By Blanchard V. Moussaoui S. Czech C. Touchet N. Bonici B. Planche M. Canton T. Jedidi I. Gohin M. Wirths O. Bayer T.A. Langui D. Duyckaerts C. Tremp G. Pradier L.

Experimental Neurology, Vol. 184, Iss. 1, 2003-11 ,pp. : 247-263

Elsevier

Access to resources Recommend Favorite